Author details

Full Name

YrjÃ¶ Antero KesÃ¤niemi

Affiliation

ORCID

Career Start Year

1971

Papers

399

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36915288	Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial.		2023
37585501	Leisure time and occupational physical activity, overall and cardiovascular mortality: a 24-year follow-up in the OPERA study.		2023
36893361	Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.		2023
37161438	Comparing ultrasonographically assessed carotid and abdominal aorta plaques in cardiovascular disease risk estimation.		2023
35171199	Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.	JAMA Cardiology	2022
35594302	Long-term metabolic fate and mortality in obesity without metabolic syndrome.		2022
35416741	Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study.	Scandinavian Journal of Clinical and Laboratory Investigation	2022
36576905	Smoking cessation and obesity-related morbidities and mortality in a 20-year follow-up study.		2022
36490299	Carotid and femoral bruits as cardiovascular risk indicators in a middle-aged Finnish population: A 20-year prospective study.		2022
34620927	Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up.	Scientific Reports	2021
34080496	Risk factors for major adverse cardiovascular events after the first acute coronary syndrome.		2021
34229196	Abdominal aorta plaques are better in predicting future cardiovascular events compared to carotid intima-media thickness: A 20-year prospective study.	Atherosclerosis	2021
33794701	Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study.	Scandinavian Journal of Clinical and Laboratory Investigation	2021
34216537	Nighttime ambulatory pulse pressure predicts cardiovascular and all-cause mortality among middle-aged participants in the 21-year follow-up.	Journal of Clinical Hypertension	2021
33651847	Resistin is a risk factor for all-cause mortality in elderly Finnish population: A prospective study in the OPERA cohort.	PLoS ONE	2021
33146452	Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis.	Echocardiography	2021
32766757	Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.	Journal of Clinical Endocrinology and Metabolism	2020
31851849	Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study).	Scandinavian Journal of Clinical and Laboratory Investigation	2020
32159395	Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study.		2020
31701776	The validity of hospital discharge register data on non-ST-elevation and ST-elevation myocardial infarction in Finland.	Scandinavian Cardiovascular Journal	2020
31092019	Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up.	Blood Pressure	2019
31586530	Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.	Am J Cardiol	2019
30479170	Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up.	Blood Pressure	2019
29496472	Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.	Lancet Diabetes and Endocrinology,The	2018
28927303	Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012.		2018
30289944	Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).	PLoS ONE	2018
29387432	SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis.	Open Heart	2018
29602140	Effect of simvastatin and ezetimibe on suPAR levels and outcomes.	Atherosclerosis	2018
29416118	Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up.	Journal of Human Hypertension	2018
29361285	Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).	Am J Cardiol	2018
29277441	IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk.	Atherosclerosis	2018
28231942	Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.	J Am Coll Cardiol	2017
28603501	Cardiac Remodeling from Middle Age to Senescence.	Frontiers in Physiology	2017
28911024	Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.	American Journal of Hypertension	2017
28341696	A Low-Frequency Inactivating <i>AKT2</i> Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.	Diabetes	2017
27423871	Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.	Metabolism: Clinical and Experimental	2017
28288202	Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.	PLoS ONE	2017
27852579	Ambulatory Blood Pressure Characteristics and Long-Term Risk for Atrial Fibrillation.	American Journal of Hypertension	2017
27823727	Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.		2016
27486164	Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).	Circulation	2016
27499378	SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.	Can J Cardiol	2016
26571029	Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).	PLoS ONE	2015
25804269	Dietary sodium intake and prediction of cardiovascular events.	European Journal of Clinical Nutrition	2015
25685360	High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.	Open Heart	2015
26555680	The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors.		2015
26341186	Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59Â Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study).	American Journal of Cardiology	2015
24730195	[Prevention of arterial diseases in the 2010s: the European treatment guideline].	Duodecim; laaketieteellinen aikakauskirja	2014
25267716	Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.	American Journal of Cardiology	2014
25257375	High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study.	Peptides	2014
24169377	[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].	Clinica e Investigacion en Arteriosclerosis	2014